MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation

Identification of effective targeted therapies for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains an unmet medical need. A patient with platinum‐refractory recurrent oral cavity HNSCC underwent comprehensive genomic profiling (CGP) that identified an activating MET mutati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Chu, Lisa Pei, Franck, Debra, Parachoniak, Christine A., Gregg, Jeffrey P., Moore, Michael G., Farwell, D. Gregory, Rao, Shyam, Heilmann, Andreas M., Erlich, Rachel L., Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj, Riess, Jonathan W.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2019
Teme:
Precision Medicine Clinic: Molecular Tumor Board
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795166/
https://ncbi.nlm.nih.gov/pubmed/31391294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0230
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki